Hyundai Electric & Energy Systems Co. will design and build an industrial energy storage system (ESS) and large-scale renewable power plants, in cooperation with Pacifico Energy Korea, a South Korean unit of US Pacifico Energy.
Under the preliminary deal, the two entities will expand bilateral cooperation in the local renewable and distributed energy sector and the transmission and transformation of the electric power sector.
Pacifico Energy Korea, a renewable energy developer, will be the financial investor and developer of the project.
South Korea's industrial ESS and renewable power market are forecast to grow to 9 trillion won by 2030, helped by the Korean-version New Deal that would to invest 160 trillion won on energy projects by 2025.
Hyundai Electric is a unit of shipbuilding group Hyundai Heavy Industries Group.
Pacifico Energy, one Japan's biggest utility-scale PV developers, has been building solar projects in South Korea and Vietnam.


Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Google Secures Pentagon AI Deal for Classified Projects
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 



